publication date: Sep. 21, 2018

In Brief

Soria, Mok, Jänne, and Foti win ESMO 2018 awards

The European Society for Medical Oncology has announces four distinguished oncology professionals who will receive its annual awards during the ESMO 2018 Congress in Munich. The awardees are:

Jean-Charles Soria
Jean-Charles Soria, an international lung cancer expert and pioneer in the development of anti-cancer drugs, will receive the ESMO Award. Soria has been involved in translational research related to precision medicine and tumour progression and has led multiple precision medicine trials.

Tony Mok
Tony Mok will receive the ESMO Lifetime Achievement Award 2018 for his practice-changing contribution to lung cancer. He was principal investigator of the first study confirming the application of precision medicine in advanced lung cancer. He has also led and co-led multiple international phase III studies that have defined current management of advanced lung cancer.

Pasi Jänne
Pasi A. Jänne will receive the ESMO Translational Research Award 2018 for his contribution to changing the treatment paradigm of lung cancer. Jänne’s research combines laboratory-based studies with translational research and clinical trials of novel therapeutic agents in patients with lung cancer.

Margaret Foti
Margaret Foti is the 2018 ESMO Women for Oncology Awardee in consideration of the legacy of young women, minority scientists, and investigators-in-training whose careers have been advanced as a result of her mentorship and support.


Blackwood named chief of breast surgery at Rutgers Cancer Institute

M. Michele Blackwood was named chief of breast surgery at Rutgers Cancer Institute of New Jersey.

Blackwood, an expert in complex breast malignancies, is currently the medical director and northern regional director of breast services for RWJBarnabas Health. As chief of breast … Continue reading Soria, Mok, Jänne, and Foti win ESMO 2018 awards

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.